179 results on '"Lip GYH"'
Search Results
2. Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population
3. The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: The Liverpool AF-Falls Project. A systematic review and meta-analysis
4. Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database
5. Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project
6. Effect of cardiorenal syndrome and its different subtypes on incidence of atrial fibrillation in a nationwide analysis
7. Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in patients with pacemakers and implantable cardioverter defibrillators (ICDs)
8. Association between serum potassium levels and short-term mortality in out-of-hospital cardiac arrest survivors
9. External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - a nationwide register-based study
10. The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients
11. Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation
12. Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study
13. Association between thromboembolic and bleeding risk with adverse outcomes in contemporary European atrial fibrillation patients: final analysis from the ESC-EHRA EORP AF general long-term registry
14. Incidence of atrial fibrillation in patients with diabetes mellitus: effect of sex, age and type of diabetes in a nationwide analysis
15. Number needed to treat for net effect of anticoagulation in atrial fibrillation
16. Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study
17. Comparison of bleeding risk scores in patients with atrial fibrillation and cancer
18. A validation of the 4S-AF scheme in Spanish and French patients from the EORP-AF Long-Term General Registry
19. Impact on outcomes in Europe: a cluster analysis from the ESC-EHRA EORP AF general long-term registry
20. Subclinical thyroid dysfunction and incident atrial fibrillation - a systematic review and meta-analysis
21. Pregnancy-related complications and incidence of atrial fibrillation: a systematic review and meta-analysis
22. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients
23. Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS
24. Performance of the C2HEST score to predict sustained atrial high-rate episodes in patients implanted with cardiac implantable electronic device
25. Cardiac rehabilitation is associated with lower 1-year all-cause mortality in primary pulmonary hypertension
26. Prediction of atrial fibrillation and sudden cardiac death in type 2 diabetic patients on insulin: a territory-wide observational cohort study
27. S130 Continuous positive airway pressure (CPAP) compliance in obstructive sleep apnoea/obesity hypoventilation syndrome patients: can we use digital data to identify predictors of compliance?
28. Vitamin K antagonists and changes in glomerular filtration rate in patients with atrial fibrillation
29. Should antithrombotic therapy be different in patients with atrial fibrillation and a so-called temporary cause and especially after an acute coronary syndrome?
30. Predictors of changes in glomerular filtration rate and outcomes in patients with atrial fibrillation
31. The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes
32. P1181Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
33. P1177Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry
34. 200Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program
35. 674Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials
36. 49Atrial Fibrillation and Dementia in the Oldest Old: An Analysis from the Population-Based Study 'Monzino-80 Plus'
37. P378Influence of reimbursement of non-vitamin K antagonist oral anticoagulants on overall prescription rates of oral anticoagulation: A nationwide study using the Korean National Health Insurance Data
38. P934Adverse Outcomes in Very Elderly Patients with Atrial Fibrillation: an analysis from the SPORTIF Trials
39. P1196Increasing trends in hospital-care burden of atrial fibrillation in korea, 2006 through 2015: implications for healthcare planning
40. P1195Current and future incidence and prevalence of atrial fibrillation in korea
41. P281Baseline characteristics of patients with atrial fibrillation with and without comorbid heart failure: the GLORIA-AF registry
42. P846Length of hospital stay to long-term mortality in patients with atrial fibrillation: evidence from the AFFIRM trial
43. P1694The impact of incident atrial fibrillation on the risk of adverse events for patients with end-stage renal disease undergoing dialysis: a time-dependent analysis
44. 1669Increased rate of previous stroke in asymptomatic/minimally symptomatic versus symptomatic patients with newly detected atrial fibrillation in western Europe - results from the GLORIA-AF registry
45. P849Relationship between time in therapeutic range and study-level factors in patients treated with vitamin k antagonists: a systematic review and meta-regression
46. Stroke Prevention in Atrial Fibrillation
47. Short Runs of Atrial Arrhythmia and Stroke Risk: A European-Wide Online Survey among Stroke Physicians and Cardiologists
48. Short Runs of Atrial Arrhythmia and Stroke Risk: A European-Wide Online Survey among Stroke Physicians and Cardiologists
49. Oxidised LDL lipids, statins and a blood-brain barrier
50. 536Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.